Medicines

Medicines help to prevent, treat or cure disease. Some are available over the counter, others need a prescription from a health practitioner. Find out what we’re doing to help make sure medicines in Australia are safe, good quality and accessible, and do what they say they will do.

About medicines

The different types of medicines and how they are classified.

What we do

How we make sure medicines are as safe and effective as possible.

Access to medicines

How you can access medicines and how we manage shortages.

Cost of medicines

How we keep medicines affordable for Australians.

Pharmaceutical Benefits Scheme

The Pharmaceutical Benefits Scheme (PBS) subsidises a large number of medicines to keep their cost down for Australians.

Read about the PBS

Biosimilar medicines

Some pharmaceutical companies make medicines that are very similar to existing biological medicines. These are known as biosimilar medicines. We have resources available to help you understand and have confidence in biosimilar medicines.

Biosimilar medicines resource collection

Latest news

Latest news

Nurses are an irreplaceable part of our healthcare system

An opinion piece from Professor Alison McMillan, Chief Nursing and Midwifery Officer, on the importance of nurses in our healthcare system.

Your Aged Care update #02, 2023

Your Aged Care update #02: 2023 Reminder to have your say against the Inspector‑General of Aged Care Bill, Care minutes reporting requirements, free online training, and more

Medicines Line

1300 633 424

Contact Medicines Line on 1300 MEDICINE for information on prescription, over-the-counter and other medicines (such as complementary medicines). The service is available Monday to Friday, 9 am to 5 pm AEST (excluding Victorian public holidays).

Latest resources

Latest resources

Correct claiming of regional and field nerve block items (18222 and 18225)

This fact sheet provides information to help support the correct billing of Medicare Benefits Schedule Items (MBS) 18222 and 18225 for regional or field nerve blocks.

Life Saving Drugs Program – MPS II – Review summary and expert panel recommendations for consumers

This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers

This Gaucher disease review considered 3 enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health.

Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations

This Gaucher disease review considered three enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.